CN104023744A - 用于针对金黄色葡萄球菌免疫的稳定组合物 - Google Patents

用于针对金黄色葡萄球菌免疫的稳定组合物 Download PDF

Info

Publication number
CN104023744A
CN104023744A CN201280063615.8A CN201280063615A CN104023744A CN 104023744 A CN104023744 A CN 104023744A CN 201280063615 A CN201280063615 A CN 201280063615A CN 104023744 A CN104023744 A CN 104023744A
Authority
CN
China
Prior art keywords
antigen
seq
sta006
polypeptide
esxab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280063615.8A
Other languages
English (en)
Chinese (zh)
Inventor
M·肯托尼
L·塔里
A·考斯洛维
M·索特朱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN104023744A publication Critical patent/CN104023744A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN201280063615.8A 2011-12-23 2012-12-21 用于针对金黄色葡萄球菌免疫的稳定组合物 Pending CN104023744A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161580191P 2011-12-23 2011-12-23
US61/580,191 2011-12-23
PCT/EP2012/076609 WO2013092985A1 (en) 2011-12-23 2012-12-21 Stable compositions for immunising against staphylococcus aureus

Publications (1)

Publication Number Publication Date
CN104023744A true CN104023744A (zh) 2014-09-03

Family

ID=47520086

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280063615.8A Pending CN104023744A (zh) 2011-12-23 2012-12-21 用于针对金黄色葡萄球菌免疫的稳定组合物

Country Status (5)

Country Link
US (1) US20150044251A1 (https=)
EP (1) EP2793939A1 (https=)
JP (1) JP2015500864A (https=)
CN (1) CN104023744A (https=)
WO (1) WO2013092985A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113893340A (zh) * 2021-09-30 2022-01-07 中牧实业股份有限公司 双相油佐剂口蹄疫疫苗的稳定剂及其应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012214677B2 (en) * 2011-02-08 2016-11-10 Abvacc, Inc. Immunogenic composition comprising alpha-hemolysin oligopeptides
JP6670106B2 (ja) 2012-04-26 2020-03-18 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌コアグラーゼ抗原およびその使用方法
HUE044211T2 (hu) 2012-08-31 2019-10-28 Glaxosmithkline Biologicals Sa Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék
EP3077820B1 (en) * 2013-12-03 2025-02-26 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
CN106103469B (zh) 2014-03-26 2020-11-27 葛兰素史密丝克莱恩生物有限公司 突变型葡萄球菌抗原
CN104147599B (zh) * 2014-06-24 2017-03-01 华中科技大学 一种疫苗佐剂、其制备方法及应用
WO2016095832A1 (en) * 2014-12-18 2016-06-23 The University Of Hong Kong Immunotherapeutic targets against staphylococcus aureus
EP3419654B1 (en) * 2016-02-22 2022-04-27 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
WO2023213393A1 (en) * 2022-05-04 2023-11-09 Evaxion Biotech A/S Staphylococcal protein variants and truncates

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252059A2 (fr) * 1986-06-30 1988-01-07 Smithkline Biologicals S.A. Stabilisants améliorés pour vaccins atténués, procédé pour leur préparation et vaccins les contenant
WO2007007344A1 (en) * 2004-08-27 2007-01-18 Panacea Biotec Ltd. Inactivated poliomyelitis vaccine derived from sabin strain of polio virus
WO2007027076A1 (es) * 2005-09-01 2007-03-08 Nuno Ayala Jose Luis Formula estabilizadora de vacunas con antígenos vivos para su uso en sistemas de vacunación masiva
CN1927394A (zh) * 2006-09-05 2007-03-14 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
WO2010119343A2 (en) * 2009-04-14 2010-10-21 Novartis Ag Compositions for immunising against staphylococcus aureus
CN102258537A (zh) * 2011-07-15 2011-11-30 骆延波 鸡传染性法氏囊病特异性转移因子的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
DE69530196T2 (de) * 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
NZ508013A (en) 1998-05-07 2003-08-29 Corixa Corp Adjuvant composition for use with an antigen in a vaccine composition
KR100629028B1 (ko) 1998-10-16 2006-09-26 글락소스미스클라인 바이오로지칼즈 에스.에이. 애쥬번트 시스템 및 백신
WO2000046147A2 (en) 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
WO2000076476A1 (en) * 1999-06-11 2000-12-21 Endorex Corporation Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination
DE60039450D1 (de) * 1999-12-02 2008-08-21 Novartis Vaccines & Diagnostic Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung
JP5118798B2 (ja) * 2000-03-07 2013-01-16 メルク・シャープ・エンド・ドーム・コーポレイション アデノウイルス製剤
WO2003087327A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
EP2481819A1 (en) * 2003-02-25 2012-08-01 MedImmune Vaccines, Inc. Cross flow filtration in the production of stabilized influenza vaccine compositions
CA2542777C (en) * 2003-10-23 2016-02-02 Chiron Corporation Stabilised compositions
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
EP2848692B1 (en) * 2004-05-21 2017-08-16 Novartis Vaccines and Diagnostics, Inc. Alphavirus vectors for influenza virus vaccines
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8097584B2 (en) * 2005-05-25 2012-01-17 Novo Nordisk A/S Stabilized formulations of insulin that comprise ethylenediamine
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
EP1954308B1 (en) * 2005-09-16 2011-09-07 Merial Ltd. Stabilizers for freeze-dried vaccines
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
US20080131457A1 (en) 2006-06-12 2008-06-05 Nabi Biopharmaceuticals Use of alpha-toxin for treating and preventing staphylococcus infections
EA015817B1 (ru) 2006-10-12 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
JP5658564B2 (ja) 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
WO2011027222A2 (en) 2009-09-02 2011-03-10 Novartis Ag Immunogenic compositions including tlr activity modulators

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252059A2 (fr) * 1986-06-30 1988-01-07 Smithkline Biologicals S.A. Stabilisants améliorés pour vaccins atténués, procédé pour leur préparation et vaccins les contenant
WO2007007344A1 (en) * 2004-08-27 2007-01-18 Panacea Biotec Ltd. Inactivated poliomyelitis vaccine derived from sabin strain of polio virus
WO2007027076A1 (es) * 2005-09-01 2007-03-08 Nuno Ayala Jose Luis Formula estabilizadora de vacunas con antígenos vivos para su uso en sistemas de vacunación masiva
CN1927394A (zh) * 2006-09-05 2007-03-14 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
WO2010119343A2 (en) * 2009-04-14 2010-10-21 Novartis Ag Compositions for immunising against staphylococcus aureus
CN102258537A (zh) * 2011-07-15 2011-11-30 骆延波 鸡传染性法氏囊病特异性转移因子的制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAVALLIN A ET AL: "The spectral and thermodynamic properties of staphylococcal enterotoxin A,E,and variants suggest that structural modification are improtant to control their function", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》, vol. 275, no. 3, 21 January 2000 (2000-01-21), pages 1665 - 1672 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113893340A (zh) * 2021-09-30 2022-01-07 中牧实业股份有限公司 双相油佐剂口蹄疫疫苗的稳定剂及其应用

Also Published As

Publication number Publication date
JP2015500864A (ja) 2015-01-08
WO2013092985A1 (en) 2013-06-27
EP2793939A1 (en) 2014-10-29
US20150044251A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
CN104023744A (zh) 用于针对金黄色葡萄球菌免疫的稳定组合物
US9926344B2 (en) Stabilised proteins for immunising against Staphylococcus aureus
KR20120034612A (ko) 황색 포도상구균에 대한 면역화를 위한 조성물
US10328140B2 (en) Mutant staphylococcal antigens
US20150202277A1 (en) Stabilised proteins for immunising against staphylococcus aureus
EP2925355B1 (en) Pseudomonas antigens and antigen combinations
US20150203543A1 (en) Stabilised proteins for immunising against staphylococcus aureus
US20150273041A1 (en) Staphylococcus aureus sdre cnab domain and its use for vaccination
US20150191513A1 (en) Stabilised proteins for immunising against staphylococcus aureus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140903